Rob Ball, CEO of Genesis Innovation Group will be a Keynote Panelist at OMTEC 2019.
Read More
HOLLAND, Mich., April 18th, 2019—Genesis Innovation Group’s Shoulder Innovations (SI) is focused on human centered design.
HOLLAND, Mich., April 11, 2019 — Genesis Innovation Group and their cultivate(MD) Capital Fund I and cultivate(MD) Seed Fund, funds focused on investments into early-stage healthcare companies with innovative technologies,…
HOLLAND, Mich., March 4th, 2019– Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its investment into Embody, Inc.
Genesis will be hosting a special Workshop at the 2019 ASAP Meeting.
A venture capital fund in the region has invested in a medical startup on the state’s east side.
A venture capital fund in the region focused on early stage health care companies with innovative technologies has made a new out-of-state investment.
HOLLAND, Mich., November 20th, 2018—Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments in early-stage healthcare companies with innovative technologies, announces its investment into Medical Ingenuities, LLC.
HOLLAND, Mich., Nov. 5, 2018 /PRNewswire/ — Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System. This is a key addition to…
HOLLAND, Mich., July 19, 2018— Genesis Innovation Group, LLC, announces the formation of HAPPE Spine LLC as well as investments by cultivate(MD) Capital Fund I, LLC and cultivate(MD) Seed Fund…
